Cosmos Health Inc.
COSM- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001474167
In the last 90 days, Cosmos Health Inc. insiders filed 2 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $389.5K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Cosmos Health Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 4 | 7 | +3 |
| Shares | 783.7K | 1.62M | +836.2K (+106.7%) |
| Value | $3.15M | $600.0K | −$2.55M (−81.0%) |
New holders (5)
Institutions that held Cosmos Health Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 675,908 | $250.0K | 0.04% |
| Morgan Stanley | 56,179 | $21.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 21,664 | $8.00K | 0.00% |
| Washington Trust Co | 1,500 | $1.00K | 0.00% |
| Wells Fargo & Company | 61 | $0 | 0.00% |
Sold out (2)
Institutions that held Cosmos Health Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Hudson Bay Capital Management LP | 755,802 | $1.59M |
| Two Sigma Securities, LLC | 10,200 | $22.0K |